US medical device maker, Abbott, is moving into making general purpose consumer biosensing wearables. The company has been making continuous glucose monitor (CGM) hardware for diabetes management for years (since 2014) — but in a healthtech keynote at CES yesterday, Abbott’s chairman and CEO, Robert B Ford, announced it’s developing a new line of consumer […]...
-
Abbott tells CES it’s getting into consumer biowearables
techcrunch.com
